(Q51828644)

13 April 2018

title

Influence of UDP-Glucuronosyltransferase Polymorphisms on Stable Warfarin Doses in Patients with Mechanical Cardiac Valves. (English)

1 reference

13 April 2018

1 reference

4

Hye Sun Gwak

1 reference

13 April 2018

Kyung Eun Lee

series ordinal

3

object named as

Kyung Eun Lee

1 reference

13 April 2018

author name string

Sook Hee An

series ordinal

1

1 reference

13 April 2018

Byung Chul Chang

series ordinal

2

1 reference

13 April 2018

publication date

29 July 2015

1 reference

13 April 2018

Cardiovascular Therapeutics

published in

1 reference

13 April 2018

volume

33

1 reference

13 April 2018

issue

6

1 reference

13 April 2018

page(s)

324-328

1 reference

13 April 2018

Understanding the pharmacogenetic approach to warfarin dosing

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12147

A randomized trial of genotype-guided dosing of warfarin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12147

Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12147

Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12147

CYP4F2 genetic variant alters required warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12147

CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12147

Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12147

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12147

Impact of CYP2C9*3, VKORC1-1639, CYP4F2rs2108622 genetic polymorphism and clinical factors on warfarin maintenance dose in Han-Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12147

Assessing cytochrome P450 and UDP-glucuronosyltransferase contributions to warfarin metabolism in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12147

Glucuronidation of monohydroxylated warfarin metabolites by human liver microsomes and human recombinant UDP-glucuronosyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12147

Warfarin and UDP-glucuronosyltransferases: writing a new chapter of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12147

Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12147

Anticoagulant therapy in Japanese patients with mechanical mitral valves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12147

Association of UGT1A1 variants and hyperbilirubinemia in breast-fed full-term Chinese infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12147

Quantitative trait analysis of polymorphisms in two bilirubin metabolism enzymes to physiologic bilirubin levels in Chinese newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12147

Polymorphisms of CYP2C9, VKORC1, MDR1, APOE and UGT1A1 genes and the therapeutic warfarin dose in Brazilian patients with thrombosis: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12147

Hydroxywarfarin metabolites potently inhibit CYP2C9 metabolism of S-warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12147

21 January 2018

Identifiers

DOI

10.1111/1755-5922.12147

1 reference

13 April 2018

1 reference

13 April 2018